| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.031 | 13.868 | 19.747 | 17.523 | 11.187 | 6.523 | 7.501 | 9.740 | 29.505 | 28.732 |
| Total Income - EUR | 8.074 | 13.908 | 19.752 | 17.554 | 12.800 | 6.523 | 7.501 | 9.741 | 29.540 | 28.996 |
| Total Expenses - EUR | 16.060 | 23.877 | 30.109 | 21.969 | 14.328 | 10.592 | 17.264 | 21.661 | 14.972 | 20.583 |
| Gross Profit/Loss - EUR | -7.986 | -9.969 | -10.356 | -4.415 | -1.528 | -4.069 | -9.763 | -11.920 | 14.568 | 8.413 |
| Net Profit/Loss - EUR | -8.229 | -10.147 | -10.554 | -4.941 | -1.912 | -4.264 | -9.988 | -12.213 | 12.237 | 7.067 |
| Employees | 1 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Optilus Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 551 | 382 | 220 | 63 | 0 | 0 | 0 |
| Current Assets | 17.740 | 19.548 | 14.980 | 7.195 | 6.982 | 7.296 | 5.645 | 4.586 | 5.529 | 26.205 |
| Inventories | 17.600 | 17.241 | 14.691 | 6.918 | 5.649 | 4.649 | 3.457 | 2.937 | 1.445 | 2.503 |
| Receivables | 114 | 2.094 | 256 | 119 | 1.269 | 1.165 | 909 | 1.454 | 1.651 | 2.786 |
| Cash | 26 | 213 | 33 | 159 | 64 | 1.482 | 1.278 | 195 | 2.433 | 20.916 |
| Shareholders Funds | -17.428 | -27.444 | -37.534 | -41.786 | -42.889 | -46.341 | -55.301 | -67.685 | -55.243 | -41.887 |
| Social Capital | 151 | 149 | 147 | 144 | 141 | 139 | 135 | 136 | 135 | 135 |
| Debts | 35.168 | 47.259 | 52.514 | 49.532 | 50.254 | 53.856 | 61.009 | 72.271 | 60.772 | 68.092 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4719 - 4719" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Optilus Med S.r.l.